Soligenix, Emergent team up on ricin poisoning vaccine; Liberia declared Ebola-free;

> Soligenix and Emergent BioSolutions ($EBS) announced a development partnership for a ricin poisoning vaccine. Release

> As the Ebola outbreak came to a close in Liberia this week, the country commenced its campaigns for polio and measles immunizations. More

> A Cuban lung cancer vaccine has gained approval to come to the U.S. in its first step to a possible FDA approval. Story

> VaxInnate announced the promotion of Lynda Tussey to CSO and Bruce Weaver to vice president of manufacturing, as well as the hiring of Peter Fusco, who will serve as R&D vice president, and Stephen Haworth, who will serve as vice president of clinical. Release

> New research shows that Gardasil-9 can prevent more than 80% of cervical cancers. More

> In India, an H1N1 epidemic has led to a three-fold increase in flu vaccinations. Story

And Finally... The Canadian government celebrated the birth of the royal baby with a $100,000 donation to pro-vaccine group Immunize Canada. More

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.